from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2381c/mbtD

LFCtreatmentdescriptionclass of inhibitor

-0.349

Amikacinug/mL Amikacintranslation

-0.659

Cap5-10ug/mL Capreomycintranslation

-0.481

Rox10-50 ug/mL Roxithromycintranslation

-0.648

SM2-5 ug/mL Streptomycintranslation

-0.771

Tet5-10 ug/mL Tetracyclinetranslation

-0.577

Rif0.2-5ug/mL Rifampicintranscription

-0.292

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.758

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.714

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.470

CPZ10-50 ug/mL Chlorpromazinerespiration

4.076

Clofazimine10-13 ug/mL Clofaziminerespiration

0.042

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.403

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.378

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.311

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.240

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.765

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.177

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.688

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.830

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.885

KCN5-20 ug/mL Potassium cyaniderespiration

-0.427

NaN30.2-2 mM Sodium aziderespiration

-0.542

Nigericin50 uM Nigericinrespiration

0.079

TRC10-150 ug/mL Triclosanrespiration

-0.572

TRZ10-25 ug/mL Thioridazinerespiration

1.456

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.884

menadione6-10 ug/mL Menadionerespiration

2.031

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.122

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.319

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.473

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.595

NRP_1Non-replicating persistence stage 1dosRassociated

-0.300

Amp0.2mg/mL AmpicillincellWall

-0.386

Cephalexin20-100 ug/mL CephalexincellWall

-0.200

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.132

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.346

EMB10-20 ug/mL EthambutolcellWall

-0.123

Eta12-40 ug/mL EthionamidecellWall

-0.237

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.031

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.175

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.359

BZA0.12 mg/mL BenzamidearomaticAmides

-0.286

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.007

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.639

H2O24 mM hydrogen peroxideDNAdamaging

-0.319

Levo10 ug/mL LevofloxacinDNAdamaging

-0.473

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.071

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.310

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.410

UVUV-irradiationDNAdamaging

0.347

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.343

Antimycin12.5-50 ug/mL Antimycin A?

-0.394

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.071

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.071

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.500

PA8240.2-2 ug/mL PA-824?

-0.026

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.295

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.143

Verapamil50 uM Verapamil?

-0.378

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.394

methoxatin10-20 ug/mL Methoxatin?